Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation
Open Access
- 3 March 2004
- journal article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 43 (5), 818-825
- https://doi.org/10.1016/j.jacc.2003.08.060
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Alterations in Atrial Electrophysiology and Tissue Structure in a Canine Model of Chronic Atrial Dilatation Due to Mitral RegurgitationCirculation, 2003
- Cardioprotection by long-term ETA receptor blockade and ACE inhibition in rats with congestive heart failure: mono- versus combination therapyCardiovascular Research, 2002
- Matrix MetalloproteinasesCirculation Research, 2002
- Inhibition of transcription factor NF-κB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cellsCardiovascular Research, 2001
- Angiotensin II Induces Nuclear Factor- κ B Activation in Cultured Neonatal Rat Cardiomyocytes Through Protein Kinase C Signaling PathwayJournal of Molecular and Cellular Cardiology, 2000
- Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarctionJCI Insight, 2000
- Synergistic upregulation of metalloproteinase‐9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF‐κBFEBS Letters, 1998
- Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.JCI Insight, 1994
- Atrial arrhythmiasThe Lancet, 1993
- Epidemiologic Features of Chronic Atrial FibrillationNew England Journal of Medicine, 1982